Logo image
Factors associated with bleeding and thrombosis in children receiving extracorporeal membrane oxygenation
Journal article

Factors associated with bleeding and thrombosis in children receiving extracorporeal membrane oxygenation

Heidi J. Dalton, Ron Reeder, Pamela Garcia-Filion, Richard Holubkov, Robert A. Berg, Athena Zuppa, Frank W. Moler, Thomas Shanley, Murray Pollack, Christopher Newth, …
American Journal of Respiratory and Critical Care Medicine, Vol.196(6)
2017

Abstract

Adolescent Child Child, Preschool Extracorporeal Membrane Oxygenation Female Heart Failure Hemolysis Hemorrhage Humans Incidence Infant Male Prospective Studies Respiratory Insufficiency Retrospective Studies Thrombosis Article bleeding blood transfusion brain hemorrhage brain infarction cannula centrifugal pump chest tube child cohort analysis coronary care unit extracorporeal oxygenation filter gastrointestinal hemorrhage genital bleeding hemolysis human incidence limb ischemia lung embolism lung hemorrhage major clinical study mortality risk neonatal intensive care unit observational study outcome assessment oxygenator pediatric intensive care unit priority journal prospective study risk reduction survival thrombosis urinary tract hemorrhage adolescent adverse effects clinical trial extracorporeal oxygenation female heart failure Hemorrhage infant male multicenter study preschool child Respiratory Insufficiency retrospective study thrombosis
Rationale: Extracorporeal membrane oxygenation (ECMO) is used for respiratory and cardiac failure in children but is complicated by bleeding and thrombosis. Objectives: (1) To measure the incidence of bleeding (blood loss requiring transfusion or intracranial hemorrhage) and thrombosis during ECMO support; (2) to identify factors associated with these complications; and (3) to determine the impact of these complications on patient outcome. Methods: This was a prospective, observational cohort study in pediatric, cardiac, and neonatal intensive care units in eight hospitals, carried out from December 2012 to September 2014. Measurements and Main Results: ECMO was used on 514 consecutive patients under age 19 years. Demographics, anticoagulation practices, severity of illness, circuitry components, bleeding, thrombotic events, and outcome were recorded. Survival was 54.9%. Bleeding occurred in 70.2%, including intracranial hemorrhage in 16%, and was independently associated with higher daily risk of mortality. Circuit component changes were required in 31.1%, and patient-related clots occurred in 12.8%. Laboratory sampling contributed to transfusion requirement in 56.6%, and was the sole reason for at least one transfusion in 42.2% of patients. Pump type was not associated with bleeding, thrombosis, hemolysis, or mortality. Hemolysis was predictive of subsequent thrombotic events. Neither hemolysis nor thrombotic events increased the risk of mortality. Conclusions: The incidences of bleeding and thrombosis are high during ECMO support. Laboratory sampling is a major contributor to transfusion during ECMO. Strategies to reduce the daily risk of bleeding and thrombosis, and different thresholds for transfusion, may be appropriate subjects of future trials to improve outcomes of children requiring this supportive therapy. Copyright © 2017 by the American Thoracic Society

Metrics

5 Record Views

Details

Logo image